Fluoxetine in the Management of Major Depressive Disorder in Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials

Fluoxetine in the Management of Major Depressive Disorder in Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials

Background: Fluoxetine is a serotonin-specific reuptake inhibitor antidepressant and is the only approved pharmacological treatment for major depressive disorder (MDD) in children and adolescent. Methods: We searched the published randomized controlled-trials to review fluoxetine efficacy and tolera...

Full description

Bibliographic Details
Main Authors: Girgis, E. (Author), Mishriky, R. (Author), Plaha, K. (Author), Reyad, A.A (Author)
Format: Article
Language:English
Published: SAGE Publications Ltd 2021
Subjects:
adolescent
Article
child
children and adolescent
Children's Depression Rating Scale
childrens depression rating scale revised
Clinical Global Impression scale
clinical global impressions severity of illness
controlled study
disease severity
dizziness
drug efficacy
drug safety
drug tolerability
drug withdrawal
DSM-IV
female
fluoxetine
headache
human
incidence
major depression
major depressive disorder
male
mental health
meta analysis
nausea and vomiting
placebo
psychiatric disorders
randomized controlled trial (topic)
suicidal ideation
systematic review
treatment duration
treatment outcome
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items